loading

Finanzdaten der Alaunos Therapeutics Inc-Aktie (TCRT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.002 0.004 - 0.004
Operating Expenses
5.03%
1.039
1.094 0.759 1.15 1.17
Benefits Costs and Expenses
-
- - - -
Costs And Expenses
4.94%
1.04
1.094 0.759 1.15 1.17
Operating Income/Loss
4.85%
-1.039
-1.092 -0.755 -1.15 -1.166
Nonoperating Income/Loss
163.16%
-0.012
0.019 0.013 0.023 0.037
Income/Loss From Continuing Operations Before Tax
52,650%
-1.051
0.002 0.004 -1.127 0.004
Income/Loss From Continuing Operations After Tax
2.05%
-1.051
-1.073 -0.742 -1.127 -1.129
Net Income/Loss
2.05%
-1.051
-1.073 -0.742 -1.127 -1.129
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4.69%
1.6763
1.6013 - 1.6013 1.6013
Diluted Average Shares
4.69%
1.6763
1.6013 - 1.6013 1.6013
Basic Earnings Per Share
5.97%
-0.63
-0.67 -0.46 -0.70 -0.71
Diluted Earnings Per Share
5.97%
-0.63
-0.67 -0.46 -0.70 -0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):